May 26, 2020
Ardelyx to Present at the Jefferies 2020 Virtual Healthcare Conference
Mar 17, 2020
First FDA approved Potassium Phosphates Injection from CMP Pharma Is Now Available
Feb 27, 2020
First FDA approved Potassium Phosphates Injection from CMP Pharma Has Been Approved.
Feb 26, 2020
Ardelyx to Present at the Cowen and Company 40th Annual Health Care Conference
Feb 11, 2020
Global Hyperkalemia Market Report 2020; Forecast to 2022 - Featuring Profiles of Ardelyx, Astrazeneca, and Vifor Pharma
Sep 17, 2019
US Nephrologists Beginning to Trial AstraZeneca's LOKELMA (zirconium sodium cyclosilicate) but Unclear on Differentiation from Vifor/Relypsa's VELTASSA (patiromer FOS)
Aug 05, 2019
Randomized double-blinded study to commence on DigiFab® for kidney injury related to CABG surgery
Jan 09, 2019
Global Hyperkalemia Drugs Market to 2023: Market will Grow at a CAGR of More than 20% with Ardelyx, AstraZeneca, Perrigo, Sanofi & Vifor Pharma Dominating
Sep 10, 2018
FDA Designates AliveCor's Bloodless Hyperkalemia Test a "Breakthrough Device"
Aug 01, 2018
Ardelyx Announces Date of Second Quarter 2018 Financial Results and Conference Call
Feb 12, 2018
Ardelyx Announces Departure of Chief Scientific Officer
Nov 21, 2017
Ardelyx Announces Updated Development Path for its Cardiorenal Pipeline
Nov 16, 2017
Cardiologists Continue to Lag Nephrologists When It Comes to the Adoption of Vifor/Relypsa's Veltassa for Hyperkalemia, but Prescribers in Both Specialties Report Mounting Market Access Pressure
Nov 01, 2017
CytoSorbents Awarded Approximately $1.0 Million in Phase II SBIR Funding to Optimize New Treatment Approaches for Severe Hyperkalemia
Sep 26, 2017
New Survey of People with Chronic Kidney Disease Finds High Potassium is Among Top Health Concerns
Sep 05, 2017
CytoSorbents Highlights Important Research Advances in Traumatic Brain Injury, Hemorrhagic Shock, and Severe Hyperkalemia at the Military Health System Research Symposium
Aug 07, 2017
CMP Pharma, Inc. Announces FDA Approval of CaroSpir® (Spironolactone Oral Suspension, 25 mg/5 mL)